Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?

about

Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial.

P2860

Q55223606-11BBB067-BC8E-49A7-A33B-66FAA68CFAD5

P2860

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?

Item

http://www.wikidata.org/entity/Q47102960

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Optimizing treatment with tumo ...... practical in good responders?

@en

Optimizing treatment with tumo ...... practical in good responders?

@nl

type

Item

label

Optimizing treatment with tumo ...... practical in good responders?

@en

Optimizing treatment with tumo ...... practical in good responders?

@nl

prefLabel

Optimizing treatment with tumo ...... practical in good responders?

@en

Optimizing treatment with tumo ...... practical in good responders?

@nl

P1476

Optimizing treatment with tumo ...... practical in good responders?

@en

P2093

Ailsa Bosworth

http://www.w3.org/2001/XMLSchema#string

Beatriz Lorente-Cánovas

http://www.w3.org/2001/XMLSchema#string

Caroline J Doré

http://www.w3.org/2001/XMLSchema#string

David L Scott

http://www.w3.org/2001/XMLSchema#string

David Walker

http://www.w3.org/2001/XMLSchema#string

Ira Pande

http://www.w3.org/2001/XMLSchema#string

Margaret H Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.

The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.

British Society for Rheumatology Biologics Register.

P304

2004-2014

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEX315

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James B Galloway

Andrew P Cope

F Ibrahim

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28968858

http://www.w3.org/2001/XMLSchema#string

P921

TNF

P932

5722050

http://www.w3.org/2001/XMLSchema#string

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?

about

P2860

P2860

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932